USFDA Slaps Import Alert on Dabur's Silvassa Plant, Stock Treads Water Amid Rally
Dabur India faces fresh regulatory heat as the USFDA issued an import alert against drugs manufactured at its Silvassa facility, restricting US-bound shipments. The stock opened at ₹422.15 and traded in a tight ₹420.45–₹428.80 band on June 12, lagging a broader market rally as investors weigh the export hit on the FMCG major.
What happened
USFDA issued an import alert for drugs manufactured at Dabur India's Silvassa plant, keeping the FMCG major's stock flat on June 12 despite a broader market
Key facts
- ₹422.15 open
- ₹428.80 high
- ₹420.45 low
Why this matters
The Silvassa setback may pressure Dabur to diversify US manufacturing exposure or pursue tuck-in healthcare assets with cleaner regulatory track records to de-risk the export portfolio.